Navigation Links
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Date:5/24/2011

PALO ALTO, Calif. and AUCKLAND, New Zealand, May 24, 2011 /PRNewswire/ -- Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR), and Auckland UniServices Ltd. of Auckland, New Zealand, today announced that they have entered into a licensing agreement granting Centella exclusive rights to CEN-209, a novel investigational drug designed to enhance the effectiveness of radiotherapy and chemotherapy when treating solid tumors that are hypoxic—or oxygen-starved—and therefore resistant to standard forms of radiotherapy and chemotherapy.

CEN-209 is selectively activated in areas of low oxygen often found within solid tumors.  These areas develop within tumors due to their rapid growth, which impairs the blood vessels bringing nutrients and oxygen, resulting in hypoxia.  

"Hypoxic tumors are generally resistant to radiotherapy and to chemotherapy, and there is no effective treatment for such tumors today," says Thorsten Melcher, PhD, President of Centella Therapeutics.  "Hypoxia occurs in most types of solid tumors, but not necessarily in every patient with a given tumor type. For example, in lung cancer patients, roughly 50 percent of tumors have hypoxic regions.(1)  In the future, successful treatment of hypoxic tumors will likely require identifying affected patients and giving them a hypoxia-specific drug, like CEN-209, in addition to standard treatment."(2)

Radiotherapy works by damaging tumor cells' DNA, but only in well-oxygenated areas, whereas CEN-209 is designed to 'switch on' and damage the DNA only of hypoxic cells, leaving other cells alone," Melcher adds.  "Thus, the two treatment approaches have the potential to complement each other, and CEN-209 is specifically designed to be preferentially used in combination with radiotherapy."

Professor William Wilson and Associate Profes
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... upcoming investor conferences. On Tuesday, December 2, ... Annual Piper Jaffray Healthcare Conference.  D. Keith Grossman ... update on the company beginning at 11:30 a.m., Eastern ...
(Date:11/26/2014)... 26, 2014   Royal Philips (NYSE: ... expanded availability of its portfolio of diagnostic ... MobileDiagnost Opta[i] , ProGrade and PrimaryDiagnost[ii]. With new ... in the U.S., and availability of all these ... Philips, customers innovative solutions designed to meet the ...
(Date:11/26/2014)... , Nov. 26, 2014  Aethlon Medical, Inc. (OTCQB:AEMD), ... agreement to raise approximately $3.3 million at a price ... by one institutional healthcare focused investor. Each unit consists of ... common share purchase warrant. Each whole warrant entitles the ... of $0.30 for a period of five years from ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3
... on unmet needs of the lumbar ... ... CoreSpine Technologies, LLC, an,emerging spinal device company announced today the ... application,for minimally invasive fusion., The development of CoreSpine,s Technologies, initial ...
... Developer of Antibody Technologies to Strengthen Management Team, ... sheets: MNCN), a manufacturer and distributor of products,for animal ... Nash,Ph.D. as Chief Scientific Officer., In his new ... development activities in innovative antibody technologies for use in,the ...
Cached Medicine Technology:CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts 2Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist 2
(Date:11/26/2014)... The report “Laboratory Information System/LIS ... Hosted, SaaS), End User Labs (Clinical, Molecular Diagnostic, ... Services) - Global Forecast to 2019” provides a ... opportunities, current market trends, and strategies impacting the ... of the revenue and market growth. , Browse ...
(Date:11/26/2014)... 26, 2014 Increasing demand for ... image guided surgeries has paved way for consequent ... incidence of various types of cancers and cardiac ... in demand for these owing to their use ... media injectors market can also be attributed to ...
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 Gone are ... after cheap deals on Black Friday, which signifies the beginning ... clicking items into their shopping carts in the comfort of ... , This Friday is going to be an ... a day, with an estimated $2.48 billion in revenue for ...
(Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... Angeles orthopedic surgeon Dr. Steven Meier has enhanced ... to offer current and prospective patients an online destination ... “We’re really excited to present the new and improved ... added features make it easier than ever for current ...
(Date:11/26/2014)... 2014 Sonru, the video interviewing specialist, ... Operating Officer and Chief Marketing Officer, in addition to ... , Jeff Jones has been appointed as Chief Operating ... the role of Chief Marketing Officer. , Mr Jones ... 25-year career includes senior roles with The Walt Disney ...
Breaking Medicine News(10 mins):Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2
... of Canberra claim that they may have mastered the ... ,Positive parenting program was developed 2 years ago ... an intention to make parenting more pleasant. Minimizing stress ... was the aim. Researcher, Penny Sellers, who will develop ...
... the heir to the British throne has extended his generosity ... is in dire need of measures to get back the ... luncheon at Clarence House, his London residence, to launch an ... Kathmandu Valley, a chain of palaces and temples built by ...
... like angioplasty are the various treatments for people ... is a small industrial city in northeast Ohio. ... the country, would suggest their patients to go ... balloon catheters through arteries and sometimes placing drug-coated ...
... suspects were being interrogated by Deli Police in connection with ... in a car kidnapped a student of the Sarvodaya Kanya ... Place on Friday//. ,"We have registered a case of ... to arrest anyone," said Rameshwar Khatri, the station house officer ...
... Queensland's health system, the Australian Medical Association (AMA) has called ... Baker, AMA northern branch councilor, has said that Dr Bruce ... to improve the ailing system and added that Peter Beattie ... to health. ,He said "I think having a ...
... a man who immolated himself to protest against non-payment of ... approach// the National Human Rights Commission (NHRC) for justice. ... burns after setting fire to his clothes in front of ... company was not paying him his dues totaling Rs.200,000 ...
Cached Medicine News:Health News:Parenting skills to manage bad behaviour 2Health News:A Princely Assistance to the Nepal Heritage 2Health News:Heart Procedure numbers go haywire in an Ohio City 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: